Search All News
Race, age, income, and insurance status are all factors in the distance a stroke patient must travel to receive certified care.
It’s clear the virus can get very close to the brain. What’s less certain is whether virus is able to penetrate deeper and invade it.
Other researchers are not convinced that these biomarkers vary by race, primarily because so little Alzheimer’s research has been conducted on Black and Latinx people.
- June 13, 2021
A public battle rages over access to experimental, trial-phase drugs
- June 10, 2021
Drs. Bell and Ader will conduct a feasibility study titled, "Intervention to capture the diagnostic potential of individuals in a group-based learning or clinical environment."
- June 9, 2021
After her diagnosis of glioblastoma in 2016, she founded an organization that advocated for patients and research.
- June 8, 2021
On Monday, the FDA approved a new drug for Alzheimer’s disease—the first in nearly two decades. Biogen’s aducanumab aims to slow the cognitive decline often associated with the disease.
Source:PreventionMay 21, 2021
For someone to be diagnosed with dementia, they have to have significant decline in more than one cognitive area,” says Neuropsychologist Elise Caccappolo, Ph.D., of CUIMC